We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
A warning letter has been sent to Emcure Pharmaceuticals after an FDA facility inspection found that the company did not adequately investigate sterility failures.
Infusion Options is voluntarily recalling all lots of all sterile products within expiry to the hospital level. These products are being recalled due to a lack of assurance of sterility.